JP2019520336A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520336A5
JP2019520336A5 JP2018562547A JP2018562547A JP2019520336A5 JP 2019520336 A5 JP2019520336 A5 JP 2019520336A5 JP 2018562547 A JP2018562547 A JP 2018562547A JP 2018562547 A JP2018562547 A JP 2018562547A JP 2019520336 A5 JP2019520336 A5 JP 2019520336A5
Authority
JP
Japan
Prior art keywords
pyridyl
alanine
glucagon peptide
seq
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2018562547A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520336A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/035101 external-priority patent/WO2017210241A1/en
Publication of JP2019520336A publication Critical patent/JP2019520336A/ja
Publication of JP2019520336A5 publication Critical patent/JP2019520336A5/ja
Abandoned legal-status Critical Current

Links

JP2018562547A 2016-06-02 2017-05-31 水溶性で化学的に安定なグルカゴンペプチド Abandoned JP2019520336A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662344672P 2016-06-02 2016-06-02
US62/344,672 2016-06-02
PCT/US2017/035101 WO2017210241A1 (en) 2016-06-02 2017-05-31 Aqueously soluble & chemically stable glucagon peptides

Publications (2)

Publication Number Publication Date
JP2019520336A JP2019520336A (ja) 2019-07-18
JP2019520336A5 true JP2019520336A5 (https=) 2020-05-28

Family

ID=60478926

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018562547A Abandoned JP2019520336A (ja) 2016-06-02 2017-05-31 水溶性で化学的に安定なグルカゴンペプチド

Country Status (5)

Country Link
US (1) US10683334B2 (https=)
EP (1) EP3463415A4 (https=)
JP (1) JP2019520336A (https=)
CN (1) CN109715185A (https=)
WO (1) WO2017210241A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3128922A1 (en) * 2019-02-05 2020-08-13 Eli Lilly And Company Glucagon analog agonists and methods of using the same
WO2022173807A2 (en) * 2021-02-09 2022-08-18 The Trustees Of Indiana University Conformationally constrained glucagon analogues and their use in glucagon-single chain insulin fusion proteins

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
EP1992641A3 (en) 1998-12-07 2009-07-29 Ipsen Pharma GLP-1 analogues
US20020090646A1 (en) 2000-05-03 2002-07-11 Amgen Inc. Calcitonin-related molecules
US20070060512A1 (en) 2003-03-04 2007-03-15 Homayoun Sadeghi Dipeptidyl-peptidase protected protein
US20100022457A1 (en) 2006-05-26 2010-01-28 Bristol-Myers Squibb Company Sustained release glp-1 receptor modulators
CA2677932A1 (en) * 2007-02-15 2008-08-21 Indiana University Research And Technology Corporation Glucagon/glp-1 receptor co-agonists
US8450270B2 (en) * 2008-06-17 2013-05-28 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers
ES2610356T3 (es) * 2009-02-03 2017-04-27 Amunix Operating Inc. Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
KR101382593B1 (ko) 2010-07-21 2014-04-10 한미사이언스 주식회사 신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물

Similar Documents

Publication Publication Date Title
JP2011511753A5 (https=)
JP2011524418A5 (https=)
JP6657230B2 (ja) インクレチン−インスリンコンジュゲート
US8999940B2 (en) Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal
JP2013518115A5 (https=)
JP5584236B2 (ja) 神経ペプチドy受容体結合化合物を有する細胞毒性コンジュゲート
JP2011524420A5 (https=)
JP2016512255A5 (https=)
JP2012530145A5 (https=)
JP2010515686A5 (https=)
RU2008141280A (ru) Агонисты рецептора нейромедина u и их применение
JP2017534676A5 (https=)
RU2015101697A (ru) Аналоги глюкагона, обладающие активностью рецептора gip
JP2011526886A5 (https=)
JP2016501204A5 (https=)
JP2015532283A5 (https=)
JP2013515057A5 (https=)
KR20150131213A (ko) 인슐린-인크레틴 접합체들
JP2014516037A5 (https=)
JP2010535781A (ja) 肥満に対する処置
JP2016515620A5 (https=)
JP2016512213A5 (https=)
JP2024520861A (ja) 遺伝性ヘモクロマトーシスの治療のためのヘプシジン模倣体
KR20130083843A (ko) 디펩티드 연결된 약제
JP2017536343A5 (https=)